Description

Mirabegron (ER) (50mg) and Solifenacin succinate (5mg) MIRAGRON S 50/5 is a highly effective combination medication that contains Mirabegron 50 mg and Solifenacin 5 mg, designed to manage overactive bladder (OAB) symptoms such as frequent urination, urgency, and urinary incontinence. This dual-action formulation helps relax bladder muscles and increase bladder capacity, providing long-lasting relief from discomfort and improving quality of life. Mirabegron, a β3-adrenoceptor agonist, enhances bladder relaxation during the storage phase, while Solifenacin, an antimuscarinic agent, reduces involuntary muscle contractions. Together, they work synergistically to promote bladder control and reduce the frequency of urination. MIRAGRON S 50/5 tablets are widely prescribed for both men and women who suffer from urinary urgency, nocturia (frequent nighttime urination), and other bladder-related symptoms. Uses MIRAGRON S 50/5 (Mirabegron 50 mg + Solifenacin 5 mg) is used primarily for the treatment of overactive bladder (OAB), a condition characterized by: Sudden urge to urinate that’s difficult to control Increased frequency of urination (day and night) Urinary leakage (urge incontinence) The combination helps by: Relaxing the bladder’s smooth muscles, allowing it to hold more urine Preventing involuntary bladder contractions Reducing the urgency and frequency of urination In some cases, MIRAGRON S 50/5 may also be used in patients with neurogenic detrusor overactivity (NDO), a condition caused by neurological disorders such as multiple sclerosis or spinal cord injury. Benefits MIRAGRON S 50/5 provides a range of benefits due to its dual mechanism of action: 1. Enhanced Bladder Control The combination of Mirabegron and Solifenacin offers superior control over bladder activity, reducing involuntary contractions and minimizing sudden urges to urinate. 2. Increased Bladder Capacity Mirabegron helps the bladder relax during the filling phase, allowing it to hold a larger volume of urine before the urge to urinate occurs. 3. Reduction in Urinary Frequency Patients experience fewer trips to the bathroom, especially at night, improving sleep quality and daily comfort. 4. Improved Quality of Life By preventing embarrassing leakage incidents and reducing urinary urgency, MIRAGRON S 50/5 enhances social confidence and overall well-being. 5. Dual Mechanism for Superior Efficacy Unlike single-drug therapies, this combination provides complementary benefits — Mirabegron works through beta-3 adrenergic pathways, while Solifenacin acts through muscarinic receptor inhibition — offering broader symptom control for OAB. Side Effects While MIRAGRON S 50/5 is generally well-tolerated, some individuals may experience mild to moderate side effects. These include: Dry mouth Constipation Headache Urinary tract infection (UTI) Increased blood pressure Dizziness Nausea Abdominal pain Serious side effects are rare but may include allergic reactions, urinary retention, or severe hypertension. If you experience chest pain, swelling, or difficulty urinating, seek immediate medical attention. Conclusion MIRAGRON S 50/5 (Mirabegron 50 mg + Solifenacin 5 mg Tablets) is a trusted and advanced formulation for managing symptoms of overactive bladder (OAB). By combining two potent agents with complementary mechanisms of action, it effectively improves bladder control, reduces urinary urgency, and minimizes leakage episodes.